Robin Roberts' Miracle Monday Celebrated by Kanzius Fans
Robin Roberts made a grand announcement this morning on “Good Morning America.” And just like the rest of the early morning viewers, we’re excited and inspired about Robin’s “Miracle Monday” announcement that she plans to start the process of returning to the anchor chair next week.
As with any big news, everyone, including Robin’s co-workers, had questions about her announcement. When? How long? Why?
Recovering from a cancer diagnosis and treatment requires belief, hope, perseverance and endurance. Oncologists and investigators require the same resilience when researching cancer treatments. Rarely are the treatments short term; instead, they require a torturous journey down long roads with varying “ups and downs.” There is no singular answer to the above questions; the process is different for every cancer patient.
Similar to the obstacles that Robin faces and the questions raised about her outcomes – research for the Kanzius Noninvasive Radiowave Cancer Treatment faces its own challenges. Many questions must be answered definitively before taking the research to the FDA and ultimately to human trials. It requires more than a favorable outcome. We must understand everything about the machine, nanoparticles, radiowaves, and their interaction before human trials can begin.
Maryann Yochim (Kanzius Foundation Board President) and Mark Neidig with Robin in September, 2010.
Just as Robin’s doctors want to ensure that her mind and body can withstand the pressures of a daily routine in front of a camera, our research teams must make sure that the Kanzius Treatment will work to its potential and treat human lives effectively.
The process for Robin to return to the GMA anchor chair is full of tests that ensure she is ready and healthy enough to get back to doing what she loves. But as her doctors will tell you, a process of steps is required so that her body isn’t put to the test too soon after her bone marrow transplant. The Kanzius Noninvasive Radiowave Cancer Treatment is going through a similar process – a process that is not simple or short but is necessary and definitely worth it.
Watching our friends and loved ones battle this disease is not easy while knowing of the extreme promise that outcomes from the Houston and Pittsburgh labs offer; but, we must keep our focus on the sight of the first human patient. We strongly believe that once we reach this goal, lives will be saved and the way cancer is treated will be changed forever.
The Kanzius Foundation thanks Robin for her brave face and for inspiring all of us to move forward. As she quoted legendary coach Jimmy Valvano “Don’t ever give up…this too shall pass.”
Thank you, Robin!